epitope corresponding to amino acids 1-300 mapping at the N-terminus of DR3 of human origin
Modification Notes
Tumor necrosis factor (TNF)-related cytokines are pleiotropic factors that initiate various cellular processes including cell death, proliferation and differentiation. Their effects are mediated by a family of receptors which includes TNF-R1, TNF-R2, NGFR (nerve growth factor receptor) and FAS. The members of this family are type I membrane receptors and are charaterized by the presence of cysteine-rich repeats in their extracellular domains. Several of these receptors, including TNF-R1 and FAS, contain a region of intracellular homology, designated the death domain, known to signal apoptosis. A new death domain member of this family, DR3 (also designated Wsl-1, APO-3, TRAMP and LARD) has been shown to induce apoptosis and activation of NF˚B. DR3 is most similar in sequence to TNF-R1, but is more restricted in tissue distribution. DR3 is highly expressed in thymocytes and lymphocytes.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of DR3 of mouse, rat and human origin by WB, IP, IF and ELISA:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 1-300 mapping at the N-terminus of DR3 of human origin
Tissue Specificity
epitope corresponding to amino acids 1-300 mapping at the N-terminus of DR3 of human origin